The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
Open accessAbstract
Susceptibility to a clinically significant drug hypersensitivity syndrome associated with abacavir use seems to have a strong genetic component. We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC. We now report the results of fine recombinant genetic mapping in an expanded patient population of 248 consecutive, fully ascertained, abacavir-exposed individuals in the Western Australian HIV Cohort Study, in which 18 cases of definite abacavir hypersensitivity (7.3%) and 230 tolerant controls were identified. Haplotype mapping within patients with allelic markers of the 57.1 ancestral haplotype suggests a susceptibility locus within the 14-kb Hsp70 gene cluster.HLA-B*5701 was present in 94.4% of hypersensitive cases compared with 1.7% of controls (odds ratio, 960;P< 0.00001). A haplotypic nonsynonymous polymorphism of Hsp70-Hom(HspA1L, resulting from the substitution of residue M493T in the peptide-binding subunit) was found in combination with HLA-B*5701 in 94.4% of hypersensitive cases and 0.4% of controls (odds ratio, 3,893;P< 0.00001). Individuals with abacavir hypersensitivity demonstrated increased monocyte tumor necrosis factor expression in response to ex vivo abacavir stimulation, which was abrogated with CD8+T cell depletion. These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structure of Haplotype Blocks in the Human Genome
Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., et al. (2002) · Science · doi:10.1126/science.1069424 · Cited by 5,863
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
Self-citationTHE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES
HALDANE, B. J. B. S. (1956) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01285.x · Cited by 1,076
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
The genetics of human populations
(1974) · Journal of Human Evolution · doi:10.1016/0047-2484(74)90135-3 · Cited by 713
Heat shock proteins transfer peptides during antigen processing and CTL priming
Srivastava, P., Udono, H., Blachere, N., & Li, Z. (1994) · Immunogenetics · doi:10.1007/bf00188611 · Cited by 569
Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., & Srivastava, P. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1315 · Cited by 556
Hetherington, S., McGuirk, S., Powell, G., Cutrell, A., Naderer, O., Spreen, B., Lafon, S., Pearce, G., & Steel, H. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80132-6 · Cited by 406
Castellino, F., Boucher, P. E., Eichelberg, K., Mayhew, M., Rothman, J. E., Houghton, A. N., & Germain, R. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1957 · Cited by 404
Structure and expression of the three MHC-linked HSP70 genes
Milner, C., & Duncan Campbell, R. (1990) · Immunogenetics · doi:10.1007/bf00187095 · Cited by 392
Mizuki, N., Ota, M., Kimura, M., Ohno, S., Ando, H., Katsuyama, Y., Yamazaki, M., Watanabe, K., Goto, K., Nakamura, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1298 · Cited by 368
Common and divergent peptide binding specificities of hsp70 molecular chaperones.
Fourie, A. M., Sambrook, J. F., & Gething, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43837-9 · Cited by 284
Zanni, M. P., von Greyerz, S., Schnyder, B., Brander, K. A., Frutig, K., Hari, Y., Valitutti, S., & Pichler, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3544 · Cited by 238
Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P. K., & Nakayama, E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1303 · Cited by 235
Binder, R. J., Blachere, N. E., & Srivastava, P. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011547200 · Cited by 214
Schnyder, B., Burkhart, C., Schnyder-Frutig, K., von Greyerz, S., Naisbitt, D. J., Pirmohamed, M., Park, B. K., & Pichler, W. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6647 · Cited by 211
Sebastiani, P., Lazarus, R., Weiss, S. T., Kunkel, L. M., Kohane, I. S., & Ramoni, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633613100 · Cited by 174
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC
Ahmad, T., Neville, M. J., Marshall, S. E., Armuzzi, A., Mulcahy-Hawes, K., Crawshaw, J., Sato, H., Ling, K., Barnardo, M., Goldthorpe, S., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg066 · Cited by 162
Morshauser, R. C., Hu, W., Wang, H., Pang, Y., Flynn, G. C., & Zuiderweg, E. R. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2776 · Cited by 160
Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir
Phillips, E. J., Sullivan, J. R., Knowles, S. R., & Shear, N. H. (2002) · AIDS · doi:10.1097/00002030-200211080-00017 · Cited by 145
Self-citationDegli‐Esposti, M. A., Andreas, A., Christiansen, F., Schalke, B., Albert, E. D., & Dawkins, R. (1992) · Immunogenetics · doi:10.1007/bf00179791 · Cited by 130
Self-citationWalsh, J. S. A., Reese, M. J., & Thurmond, L. M. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00059-5 · Cited by 124
Metabolic activation in drug allergies
Park, B. K., Naisbitt, D. J., Gordon, S. F., Kitteringham, N. R., & Pirmohamed, M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00397-8 · Cited by 122
Abacavir rechallenge has to be avoided in case of hypersensitivity reaction
Escaut, L., Liotier, J.-Y., Albengres, E., et al. (1999) · AIDS · doi:10.1097/00002030-199907300-00026 · Cited by 102
Schröder, O., Schulte, K., OSTERMANN, P. A. W., Röher, H. D., Ekkernkamp, A., & Laun, R. A. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301000-00011 · Cited by 87
Molecular Aspects of Drug Recognition by Specific T Cells
Britschgi, M., von Greyerz, S., Burkhart, C., & Pichler, W. J. (2003) · Current Drug Targets · doi:10.2174/1389450033347082 · Cited by 84
Hypersensitivity Related to Abacavir in Two Members of a Family
Peyrière, H., Nicolas, J., Siffert, M., et al. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a022 · Cited by 60
Cited by
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Self-citationHLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Uncovering the roles of rare variants in common disease through whole-genome sequencing
Cirulli, E. T., & Goldstein, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2779 · Cited by 1,136
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Metadata
- Authors
- Martin, A. M., Nolan, D., Gaudieri, S., Almeida, C. A., Nolan, R., James, I., Carvalho, F., Phillips, E., Christiansen, F. T., Purcell, A. W., McCluskey, J., & Mallal, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-03-15
- Volume
- 101
- Issue
- 12
- Pages
- 4180-4185
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2122329447
- Cited by
- 452
- References
- 27
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.